Issued2026-11-13

A Clinical Super Intelligence Roadmap: Better Answers, Faster Care, and Lower Costs

RoadmapSector

Summary

Outlines health-agency priorities for safe clinical AI adoption through patient control and disclosure, interoperable data, risk-based market authorization, postmarket monitoring and outcomes-based payment.

Healthcare Implications

Health systems, developers and payers can track prospective changes to clinical evidence, monitoring, interoperability and reimbursement across FDA, CMS and HHS programs. The roadmap describes agency priorities and potential policy changes.

Impact Level

Medium

Keywords

Transparency & GovernanceSafety & RiskClinical Quality & EfficacyPrivacy & Data

Stakeholders

Providers & Health SystemsPatients & PublicPayers & PurchasersDevelopers & VendorsRegulators & Government